SCHEMBL20162490

SCHEMBL20162490

CCC[C@]12CC[C@](C(=O)O)(CC1)CC2

nearest known ligand 0.71

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.33
CYP4A11 Q02928 2/20 0.33
FFAR3 O14843 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
CCR2 P41597 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3375229 1.00 CYP4F2 (0.33) CYP4F2CYP4A11FFAR3ADORA2AADORA1
SCHEMBL10336598 0.87 CCR2 (0.39) CYP4F2CYP4A11CCR2
SCHEMBL836834 0.85 CCR2 (0.44) CYP4F2CYP4A11CCR2
SCHEMBL9652423 0.84 CCR2 (0.43) CCR2
SCHEMBL28827324 0.84 CCR2 (0.43) CYP4F2CYP4A11CCR2
SCHEMBL9477120 0.84 CCR2 (0.43) CCR2
Hydrochloric Acid SCHEMBL11038223 0.84 CCR2 (0.43) CYP4F2CYP4A11CCR2
SCHEMBL9476457 0.84 CCR2 (0.43) CCR2
SCHEMBL9479868 0.84 CCR2 (0.43) CCR2
SCHEMBL9476266 0.84 CCR2 (0.43) CCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2185007-B1 MONO- OR BICYCLIC CARBOXYLIC ACIDS AS OFF-NOTE BLOCKERS GIVAUDAN SA (CH) 2018-05-23 EP claimed
US-10172378-B2 Mono- or bicyclic carboxylic acids as off-note blockers GIVAUDAN, SA (CH) 2019-01-08 US disclosed
EP-2185007-B1 MONO- OR BICYCLIC CARBOXYLIC ACIDS AS OFF-NOTE BLOCKERS GIVAUDAN SA (CH) 2018-05-23 EP disclosed
US-20160205978-A1 MONO- OR BICYCLIC CARBOXYLIC ACIDS AS OFF-NOTE BLOCKERS GIVAUDAN SA (CH) 2016-07-21 US disclosed
US-20160205978-A1 MONO- OR BICYCLIC CARBOXYLIC ACIDS AS OFF-NOTE BLOCKERS GIVAUDAN SA (CH) 2016-07-21 US disclosed
US-20150093692-A1 PATTERN FORMING METHOD, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND RESIST FILM USED THEREFOR, AND ELECTRONIC DEVICE MANUFACTURING METHOD AND ELECTRONIC DEVICE USING THE SAMEDEVICE MANUFACTURING METHOD AND ELECTRONIC DEVICE USING THE SAME FUJIFILM CORPORATION (JP) 2015-04-02 US disclosed
US-20150093692-A1 PATTERN FORMING METHOD, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND RESIST FILM USED THEREFOR, AND ELECTRONIC DEVICE MANUFACTURING METHOD AND ELECTRONIC DEVICE USING THE SAMEDEVICE MANUFACTURING METHOD AND ELECTRONIC DEVICE USING THE SAME FUJIFILM CORPORATION (JP) 2015-04-02 US disclosed
US-20100311786-A1 MONO- OR BICYCLIC CARBOXYLIC ACIDS AS OFF-NOTE BLOCKERS GIVAUDAN SA (CH) 2010-12-09 US disclosed
US-20100311786-A1 MONO- OR BICYCLIC CARBOXYLIC ACIDS AS OFF-NOTE BLOCKERS GIVAUDAN SA (CH) 2010-12-09 US disclosed
WO-2009015504-A2 MONO- OR BICYCLIC CARBOXYLIC ACIDS AS OFF-NOTE BLOCKERS GIVAUDAN SA (CH) 2009-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311786-A1 MONO- OR BICYCLIC CARBOXYLIC ACIDS AS OFF-NOTE BLOCKERS SORD, GLUL, ASNS CYP4F2 2863/4885CYP4A11 2605/4885FFAR3 3804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.